نتائج البحث

1

Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue

المؤلفون: Martin Davidson, Matthew Maddocks, Stephanie C. Hicks, Catherine J Evans, Lesley A. Henson, Irene J Higginson

المصدر: Journal of Clinical Oncology
Henson, L, Maddocks, M, Evans, C, Davidson, M, Hicks, S & Higginson, I 2020, ' Palliative care and the management of common distressing symptoms in advanced cancer : Pain, breathlessness, nausea and vomiting, and fatigue ', Journal of Clinical Oncology, vol. 38, no. 9, pp. 905-914 . https://doi.org/10.1200/JCO.19.00470Test

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6f762a3c2013452f92383e09252f30Test
http://europepmc.org/articles/PMC7082153Test

2

Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study)

المؤلفون: Li Man, Caijun Yuan, Lizhong Zhou, Jing Shi, Xiujuan Qu, Feng Jin, Fugang Wen, Xiuna Zhang, Ying Luo, Jinglei Qu, Zan Teng, Bo Jin, Tao Sun, Lingyun Zhang, Jian Zhang, Xiuhua Jin, Ping Yu, Mingfang Zhao, Tiejun Chen, Jingyan Wang, Jun Wang, Yuyang Dong, Xiaodong Xie, Ying Chen, Jing Liu, Lingyu Fu, Jingdong Zhang, Yuee Teng, Zhenghua Wang, Yunpeng Liu, Zhitu Zhu, Yuzhi An

المصدر: Journal of Clinical Oncology. 35:3558-3565

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b7265acb82cd39b41ff943fac887e891Test
https://doi.org/10.1200/jco.2017.72.2538Test

3

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine

المؤلفون: D. R. D'Adamo, Giovanni Grignani, George D. Demetri, Brian A. Van Tine, Robert G. Maki, Patrick Schöffski, Robin L. Jones, Sant P. Chawla, Thierry Alcindor, Matthew Guo, Jean-Yves Blay

المصدر: Journal of Clinical Oncology. 35:3433-3439

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7d40b11e3e6797cbda0f18084252abTest
https://doi.org/10.1200/jco.2016.71.6605Test

4

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer

المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life

المصدر: Kim, D W, Tiseo, M, Ahn, M J, Reckamp, K L, Hansen, K H, Kim, S W, Huber, R M, West, H L, Groen, H J M, Hochmair, M J, Leighl, N B, Gettinger, S N, Langer, C J, Rodríguez, L G P A, Smit, E F, Kim, E S, Reichmann, W, Haluska, F G, Kerstein, D & Camidge, D R 2017, ' Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small-cell lung cancer : A randomized, multicenter phase II trial ', Journal of Clinical Oncology, vol. 35, no. 22, pp. 2490-2498 . https://doi.org/10.1200/JCO.2016.71.5904Test
Journal of Clinical Oncology, 35(22), 2490-2498. AMER SOC CLINICAL ONCOLOGY
Kim, D-W, Tiseo, M, Ahn, M-J, Reckamp, K L, Hansen, K H, Kim, S-W, Huber, R M, West, H L, Groen, H J M, Hochmair, M J, Leighl, N B, Gettinger, S N, Langer, C J, Paz-Ares Rodríguez, L G, Smit, E F, Kim, E S, Reichmann, W, Haluska, F G, Kerstein, D & Camidge, D R 2017, ' Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer : A Randomized, Multicenter Phase II Trial ', Journal of Clinical Oncology, vol. 35, no. 22, pp. 2490-2498 . https://doi.org/10.1200/JCO.2016.71.5904Test
Journal of Clinical Oncology, 35(22), 2490-2498. American Society of Clinical Oncology

مصطلحات موضوعية: 0301 basic medicine, Alectinib, Male, Cancer Research, Lung Neoplasms, Pyridines, PROGRESSION, Gastroenterology, CERITINIB, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Prospective Studies, Aged, 80 and over, Brain Neoplasms, Headache, Nausea, Middle Aged, CHEMOTHERAPY, OPEN-LABEL, ALK INHIBITORS, Treatment Outcome, Oncology, AP26113, 030220 oncology & carcinogenesis, SAFETY, Retreatment, Disease Progression, Female, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Brigatinib, Adolescent, medicine.drug_class, BRAIN METASTASES, Antineoplastic Agents, Disease-Free Survival, 03 medical and health sciences, Young Adult, Organophosphorus Compounds, Crizotinib, Internal medicine, Journal Article, medicine, Humans, Lung cancer, Aged, Ceritinib, business.industry, POTENT, Receptor Protein-Tyrosine Kinases, medicine.disease, Lorlatinib, Surgery, ALK inhibitor, 030104 developmental biology, Pyrimidines, Cough, Pyrazoles, business, RESISTANCE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083080d9737f1d34cfb6ab09cbebadb2Test
https://research.rug.nl/en/publications/5541b9aa-c9cc-4d74-bb75-505038ae3276Test

5

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO)

المؤلفون: Renata Kellnerová, Anna Walaszkowska-Czyz, Laurentia Gales, Matti Aapro, Maryna Rubach, Alexandru Calim Grigorescu, Adam Pluzanski, Guenther G. Steger, Edgar Petru, Nicolay Yordanov, Petra Tesarova, Razvan-Ovidiu D. Curca, Marika Chrápavá, Bára Karlínová

المصدر: Journal of Clinical Oncology. 38:12083-12083

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Nausea, medicine.drug_class, Guideline compliance, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, medicine, Antiemetic, medicine.symptom, Intensive care medicine, business, 030215 immunology, Chemotherapy-induced nausea and vomiting

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b1114b147a50de6a5c0c73ddacbb01edTest
https://doi.org/10.1200/jco.2020.38.15_suppl.12083Test

6

A placebo controlled, randomized, double-blinded trial of olanzapine for the treatment of chronic nausea and/or vomiting, unrelated to chemotherapy/radiation

المؤلفون: Rudolph M. Navari

المصدر: Journal of Clinical Oncology. 37:118-118

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::70e76fc6bca805d8552b5c1f23deb81cTest
https://doi.org/10.1200/jco.2019.37.31_suppl.118Test

7

Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors

المؤلفون: Clayton D. Knox, Amit Mahipal, Heather Hirsch, Neeta Somaiah, Andrew J. Wagner, Amy O. Johnson-Levonas, Giuseppe Russo, David S. Hong, Raymond L. H. Lam, Shelonitda Rose, Udai Banerji, Craig Fancourt, Amy Meister

المصدر: Journal of Clinical Oncology. 35:1304-1311

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d77afcdf8e2fbafe41e84e2fec7e76Test
https://doi.org/10.1200/jco.2016.70.7117Test

8

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma

المصدر: Journal of Clinical Oncology. 34:3166-3174

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::78d10dae3ea1fa1f76b1fecc4dcf97bdTest
https://doi.org/10.1200/jco.2016.67.6346Test

9

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2

المؤلفون: Makoto Nishio, Jie Zhang, Chetachi Emeremni, Myung-Ju Ahn, Lucio Crinò, David R. Spigel, Tony Mok, Toyoaki Hida, Enriqueta Felip, Filippo de Marinis, Massimiliano Quadrigli, Giorgio V. Scagliotti, Alice T. Shaw, Fabrice Branle, Heather A. Wakelee, Harry J.M. Groen

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Journal of Clinical Oncology, 34(24), 2866-2878. AMER SOC CLINICAL ONCOLOGY

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Organoplatinum Compounds, Pyridines, medicine.medical_treatment, Phases of clinical research, Gastroenterology, DISEASE, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Gene Order, Medicine, Anaplastic Lymphoma Kinase, Sulfones, Aged, 80 and over, Brain Neoplasms, Middle Aged, Editorial, Tolerability, 030220 oncology & carcinogenesis, Female, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, Nausea, BRAIN METASTASES, 03 medical and health sciences, Crizotinib, Internal medicine, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Chemotherapy, Ceritinib, business.industry, KINASE INHIBITORS, Receptor Protein-Tyrosine Kinases, Cancer, medicine.disease, Pyrimidines, 030104 developmental biology, Pyrazoles, business, RESISTANCE

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef7ba5e0416811073545a0b2fe9d457Test
https://doi.org/10.1200/jco.2015.65.5936Test

10

Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response

المؤلفون: Sharon Tuck, Marie Fallon, Barry Laird, Pål Klepstad, Marianne Jensen Hjermstad, Donald C. McMillan, Stein Kaasa

المصدر: Laird, B J A, Fallon, M, Hjermstad, M J, Tuck, S, Kaasa, S, Klepstad, P & McMillan, D C 2016, ' Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response ', Journal of Clinical Oncology, vol. 34, no. 23, pp. 2769-2775 . https://doi.org/10.1200/JCO.2015.65.7742Test

مصطلحات موضوعية: Diarrhea, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, MEDLINE, Appetite, Pain, Systemic inflammation, Severity of Illness Index, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Neoplasms, Internal medicine, Severity of illness, Humans, Medicine, In patient, Patient Reported Outcome Measures, Fatigue, Aged, Performance status, business.industry, Cancer, Nausea, Middle Aged, medicine.disease, Biobank, Systemic Inflammatory Response Syndrome, C-Reactive Protein, Dyspnea, 030104 developmental biology, 030220 oncology & carcinogenesis, Quality of Life, Physical therapy, Female, medicine.symptom, Sleep, business, Constipation

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a6c80de09be6141c5b0e0888951aeeTest
https://doi.org/10.1200/jco.2015.65.7742Test

تنقيح النتائج